FibroGen, Inc. is a research-based biotechnology company. It is focused on the discovery, development, and commercialization of therapeutic agents for treatment of anemia, fibrosis, cancer, and other serious unmet medical needs. The Company develops Roxadustat that is in Phase III clinical development for the treatment of anemia in chronic kidney disease; and FG-3019 which is in Phase II clinical development for the treatment of idiopathic pulmonary fibrosis, pancreatic cancer, and liver fibrosis. FibroGen, Inc. is headquartered in San Francisco, California.
Address Details
Address: 409 ILLINOIS STREET
City: SAN FRANCISCO
State: CA
Country: USA
Zip Code: 94158
Contact Details
415-978-1200
This weeks newsletter: 🚀 Retail Access to SpaceX, BlackBerry’s Big Moves, Trends to Watch 📈